HeartSciences Inc. Extends Loan Maturity to 2026 in Amended Financing Agreement with Front Range Ventures

Reuters10-02

<a href="https://laohu8.com/S/HSCS">HeartSciences Inc</a>. Extends Loan Maturity to 2026 in Amended Financing Agreement with Front Range Ventures

**HeartSciences Inc. Extends Loan Maturity Date with Front Range Ventures** HeartSciences Inc. announced it has entered into Amendment No. 7 to its existing Loan and Security Agreement with Front Range Ventures LLC (FRV), further extending the maturity date of its $500,000 secured promissory note. Under the new terms, the maturity date has been pushed back to September 30, 2026. HeartSciences will pay all accrued unpaid interest as of September 30, 2025, by that date, with any subsequent interest due at maturity. The company also retains the option to repay any or all of the outstanding principal, with a minimum repayment of $50,000, at any time before the new maturity date. The note continues to bear interest at 12% per annum, compounded annually.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartsciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-227023), on October 01, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2572684955?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-02 05:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2572684955","market":"us","top_or_hot":-1,"title":"HeartSciences Inc. Extends Loan Maturity to 2026 in Amended Financing Agreement with Front Range Ventures","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/HSCS\">HeartSciences Inc</a>. Extends Loan Maturity to 2026 in Amended Financing Agreement with Front Range Ventures\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        **HeartSciences Inc. Extends Loan Maturity Date with Front Range Ventures** HeartSciences Inc. announced it has entered into Amendment No. 7 to its existing Loan and Security Agreement with Front Range Ventures LLC (FRV), further extending the maturity date of its $500,000 secured promissory note. Under the new terms, the maturity date has been pushed back to September 30, 2026. HeartSciences will pay all accrued unpaid interest as of September 30, 2025, by that date, with any subsequent interest due at maturity. The company also retains the option to repay any or all of the outstanding principal, with a minimum repayment of $50,000, at any time before the new maturity date. The note continues to bear interest at 12% per annum, compounded annually.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartsciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-227023), on October 01, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HeartSciences Inc. Extends Loan Maturity to 2026 in Amended Financing Agreement with Front Range Ventures</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHeartSciences Inc. Extends Loan Maturity to 2026 in Amended Financing Agreement with Front Range Ventures\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-02 05:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/HSCS\">HeartSciences Inc</a>. Extends Loan Maturity to 2026 in Amended Financing Agreement with Front Range Ventures\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        **HeartSciences Inc. Extends Loan Maturity Date with Front Range Ventures** HeartSciences Inc. announced it has entered into Amendment No. 7 to its existing Loan and Security Agreement with Front Range Ventures LLC (FRV), further extending the maturity date of its $500,000 secured promissory note. Under the new terms, the maturity date has been pushed back to September 30, 2026. HeartSciences will pay all accrued unpaid interest as of September 30, 2025, by that date, with any subsequent interest due at maturity. The company also retains the option to repay any or all of the outstanding principal, with a minimum repayment of $50,000, at any time before the new maturity date. The note continues to bear interest at 12% per annum, compounded annually.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartsciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-227023), on October 01, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HSCS","symbol_name":"HeartSciences Inc","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nNDL5HcbM0:1","article_id":"2572684955","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2572684955","pubTimestamp":1759353859,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"**HeartSciences Inc. Extends Loan Maturity Date with Front Range Ventures** HeartSciences Inc. announced it has entered into Amendment No. 7 to its existing Loan and Security Agreement with Front Range Ventures LLC , further extending the maturity date of its $500,000 secured promissory note. Under the new terms, the maturity date has been pushed back to September 30, 2026. HeartSciences will pay all accrued unpaid interest as of September 30, 2025, by that date, with any subsequent interest due at maturity. The company also retains the option to repay any or all of the outstanding principal, with a minimum repayment of $50,000, at any time before the new maturity date. The note continues to bear interest at 12% per annum, compounded annually.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HSCS":"HeartSciences Inc","BK4082":"医疗保健设备"},"translate_title":"HeartSciences Inc.在与Front Range Ventures修订后的融资协议中将贷款期限延长至2026年","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HSCS":0.9},"content_text":"HeartSciences Inc. Extends Loan Maturity to 2026 in Amended Financing Agreement with Front Range Ventures\n    \n\n        **HeartSciences Inc. Extends Loan Maturity Date with Front Range Ventures** HeartSciences Inc. announced it has entered into Amendment No. 7 to its existing Loan and Security Agreement with Front Range Ventures LLC (FRV), further extending the maturity date of its $500,000 secured promissory note. Under the new terms, the maturity date has been pushed back to September 30, 2026. HeartSciences will pay all accrued unpaid interest as of September 30, 2025, by that date, with any subsequent interest due at maturity. The company also retains the option to repay any or all of the outstanding principal, with a minimum repayment of $50,000, at any time before the new maturity date. The note continues to bear interest at 12% per annum, compounded annually.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartsciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-227023), on October 01, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2572684955","isCrawlerRequest":true}